Isolated Limb Infusion as First, Second, or Third or Later-Line Therapy for Metastatic In-Transit Melanoma.

No statistically significant differences were found in OS or DSS based on ILI line of therapy (although DSS between therapies approached significance) ( P = 0.35 and P = 0.07, respectively) ( Figure 2 ).

also in 8,237 other papers